A new report has found that individual executives in health care are now being targeted in fraud cases that used to be reserved for corporations as a whole. The report, released by , revealed that federal enforcers are making it their business to blame the execs at the top of corporation chain for fraud issues related to Medicaid and Medicare.
Execs in Many Areas of Health Targeted
According to the report, the new tactic by the fed is to target the people in charge of running health-related companies when they detect fraud in relation to health insurance or health care.
This means the corporate execs in charge at drug companies, major health care enterprises, medical device manufacturers and even nursing home chains could be targeted if they are suspected of fraud.
This approach is a sharp contrast to previous fraud investigations where if a company was caught in a fraudulent act, lawyers would be able to negotiate a financial settlement, allowing the company to write a check to the government and promise never to break the rules again.
While this approach would let the company off the hook, the costs associated with the settlement would often be passed down to customers.
To avoid this issue, federal enforcers are now looking to have the companies pay fines are pushing to have senior execs face criminal charges.
Recent Comments